Cancer diagnostics company Pacific Edge is looking to raise $80 million, just weeks after denying it was looking to raise A$70m following an announcement to the Australian Stock Exchange.
The NZX-listed company has gone into a trading halt this morning as it announced the capital raise,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).